90 related articles for article (PubMed ID: 2214303)
1. [Neuronal death and neurotrophic factors in Alzheimer's disease].
Uchida Y; Tomonaga M
Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):293-7. PubMed ID: 2214303
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
3. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
4. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
5. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
6. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
Shin RW; Ogomori K; Kitamoto T; Tateishi J
Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
[TBL] [Abstract][Full Text] [Related]
7. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease].
Dessi F; Colle MA; Hauw JJ; Duyckaerts C
Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388
[TBL] [Abstract][Full Text] [Related]
8. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
Gómez-Isla T; Hollister R; West H; Mui S; Growdon JH; Petersen RC; Parisi JE; Hyman BT
Ann Neurol; 1997 Jan; 41(1):17-24. PubMed ID: 9005861
[TBL] [Abstract][Full Text] [Related]
9. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
10. [Neuronal DNA damage correlates with a positive detection of c-Jun, nuclear factor kB, p53 and Par-4 transcription factors in Alzheimer's disease].
García-Ospina GP; Jímenez-Del Río M; Lopera F; Vélez-Pardo C
Rev Neurol; 2003 Jun 1-15; 36(11):1004-10. PubMed ID: 12808492
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of synaptic dysfunction in Alzheimer's disease.
Masliah E
Histol Histopathol; 1995 Apr; 10(2):509-19. PubMed ID: 7599445
[TBL] [Abstract][Full Text] [Related]
12. Is pigment epithelium-derived factor level in cerebrospinal fluid a promising biomarker for early diagnosis of Alzheimer's disease?
Yamagishi S; Inagaki Y; Takeuchi M; Sasaki N
Med Hypotheses; 2004; 63(1):115-7. PubMed ID: 15193361
[TBL] [Abstract][Full Text] [Related]
13. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons.
Wang DC; Chen SS; Lee YC; Chen TJ
Neurosci Lett; 2006 May; 398(1-2):78-82. PubMed ID: 16412575
[TBL] [Abstract][Full Text] [Related]
15. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of regeneration in Alzheimer's disease brain.
Uchida Y
Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S158-68. PubMed ID: 20590831
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
18. Life and death of neurons in the aging cerebral cortex.
Morrison JH; Hof PR
Int Rev Neurobiol; 2007; 81():41-57. PubMed ID: 17433917
[TBL] [Abstract][Full Text] [Related]
19. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
[TBL] [Abstract][Full Text] [Related]
20. Neuritic pathology and dementia in Alzheimer's disease.
McKee AC; Kosik KS; Kowall NW
Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
